Last $15.30 USD
Change Today +0.55 / 3.73%
Volume 22.0K
QURE On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 12:27 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

uniqure b.v. (QURE) Snapshot

Open
$14.66
Previous Close
$14.75
Day High
$15.31
Day Low
$14.66
52 Week High
02/26/14 - $18.75
52 Week Low
05/22/14 - $8.29
Market Cap
266.0M
Average Volume 10 Days
75.4K
EPS TTM
--
Shares Outstanding
17.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for UNIQURE B.V. (QURE)

Related News

No related news articles were found.

uniqure b.v. (QURE) Related Businessweek News

No Related Businessweek News Found

uniqure b.v. (QURE) Details

uniQure BV, a biopharmaceutical company, develops gene therapies through its modular technology platform for the treatment of genetic or acquired diseases. The company offers Glybera for the treatment of patients with lipoprotein lipase deficiency, an orphan metabolic disease. It also develops a pipeline of additional adeno-associated virus (AAV) based gene therapies, including AMT-060, a gene therapy for the treatment of hemophilia B; AMT-021 for acute intermittent porphyria; AMT-110 for Sanfilippo B syndrome; and AAV2/glial cell line-derived neurotrophic factor for Parkinson's disease, as well as various programs that are in early preclinical development stage. The company has collaborations with Chiesi Farmaceutici S.p.A., Digna Biotech, Institut Pasteur, and University of California San Francisco. uniQure BV was founded in 1998 and is headquartered in Amsterdam, the Netherlands.

87 Employees
Last Reported Date: 04/25/14
Founded in 1998

uniqure b.v. (QURE) Top Compensated Officers

Chief Executive Officer, Managing Director an...
Total Annual Compensation: €480.0K
Compensation as of Fiscal Year 2013.

uniqure b.v. (QURE) Key Developments

uniQure N.V. Presents at 18th Munich Capital Markets Conference, Dec-09-2014 02:50 PM

uniQure N.V. Presents at 18th Munich Capital Markets Conference, Dec-09-2014 02:50 PM. Venue: The Charles Hotel, Munich, Germany.

uniQure N.V. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-11-2014 09:45 AM

uniQure N.V. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-11-2014 09:45 AM. Venue: The Crowne Plaza Hotel, New York, New York, United States. Speakers: Jörn Aldag, Chief Executive Officer, Managing Director and Member of Management Board.

uniQure N.V. Announces Unaudited Consolidated Earnings Results for Third Quarter and Nine Months Ended Sept. 30, 2014

uniQure N.V. announced unaudited consolidated earnings results for third quarter and nine months ended Sept. 30, 2014. For the quarter, the company reported total revenues of EUR 1,293,000, operating loss of EUR 5,386,000, loss before corporate income tax of EUR 7,038,000, net loss of EUR 7,038,000 or EUR 0.61 per basic and diluted share compared to the total revenues of EUR 1,001,000, operating loss of EUR 7,893,000, loss before corporate income tax of EUR 9,059,000, net loss of EUR 9,059,000 or EUR 0.51 per basic and diluted share for the same quarter a year ago. For the year to date, the company reported total revenues of EUR 2,051,000, operating loss of EUR 15,580,000, loss before corporate income tax of EUR 20,002,000, net loss of EUR 20,002,000 or EUR 1.94 per basic and diluted share, net cash provided by operating activities of EUR 1,654,000, purchases of property, plant and equipment of EUR 536,000, purchases of intangible assets of EUR 3,623,000 compared to the total revenues of EUR 3,213,000, operating loss of EUR 24,270,000, loss before corporate income tax of EUR 25,879,000, net loss of EUR 25,879,000 or EUR 1.54 per basic and diluted share, net cash used in operating activities of EUR 16,919,000, purchases of property, plant and equipment of EUR 13,365,000, purchases of intangible assets of EUR 2,129,000 for the same period a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QURE:US $15.12 USD +0.37

QURE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for QURE.
View Industry Companies
 

Industry Analysis

QURE

Industry Average

Valuation QURE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 50.5x
Price/Book 4.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 30.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNIQURE B.V., please visit www.uniqure.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.